Community Practice

Latebreakers: CDC updates gonorrhea treatment guide

Impetigo is a bacterial skin condition common in children and characterized by blisters that may itch. Now there is a new antibacterial ointment approved to treat this condition. Retapamulin (Altabax 1%, GlaxoSmithKline) is the first of a new class of antibacterials known as pleuromutilins. According to the manufacturer, no other antibacterials use the same specific mode of action.

Latebreakers: CCRx tops for customer satisfaction

Latebreakers: CVS completes label improvements

Latebreakers: Walgreens names new chairman, president

Latebreakers: Nonprofit focuses on helping pharmacies

Latebreakers: Many N.Y. pharmacies fail to offer foreign language labels

Latebreakers: Pfizer to pay nearly $20 million in PBM kickback scheme

Latebreakers Study: High workload, technology, alert systems increase med errors

McKesson's Health Mart franchise wins Drug Topics' 2007 Pharmacy Chain of the Year Award.

NACDS members meet their new association leader, Steven Anderson

From coughs and colds to analgesics, pharmacists give their top two OTC brand recommendations in this exclusive Drug Topics survey.

A 20/20 episode provokes strong pharmacy reactions, including the call for technician training programs to meet rigorous standards.

Rxs, generics, OTCs, home healthcare items

E-record security; e-prescribing accreditation; bar codes smaller; Parata gets self-service player; new Cognitive label printer; automating preauthorization; Tenn. Medicare monitoring program.

Web-based diabetes education program provides schools and students better medication therapy management (MTM) training

NIH hosts conference to weigh opioids for pain control versus increase in abuse and addiction.

CMS issues final rule for competitive acquisition program for DMEPOS suppliers

Comparative effectiveness research needed to find the best in drugs, devices, biologicals, and procedures to improve healthcare, contain costs

Drug Topics' exclusive OTC Recommendation Survey 2007 finds that R.Ph.s are providing more OTC recommendations and counseling than ever.

The use of intravenous (IV) syringes for non-IV applications such as enteral feedings poses many risks, especially for the pediatric and neonatal population which has a majority of their oral and enteral doses provided through a gastric tube. The Baxa Corporation recently announced the launch of a new educational campaign to make healthcare providers aware of these problems and offer solutions.

While persons with Medicare still are adjusting to 2007 plan changes and modifications to their coverage, Part D sponsors are preparing 2008 bids that are due in June.

CMS officials urge pharmacists to get NPI numbers and health plans to develop contingency plans.

Winn-Dixie named top pharmacy for MTM by Outcomes